Portrait of Jinbing Bai

Researcher

Jinbing Bai

PhD, MSN, RN, FAAN

Associate Professor with Tenure

Nell Hodgson Woodruff School of Nursing
Emory University

THIS PROFILE WAS GENERATED FROM PUBLICLY AVAILABLE SOURCES AND REVIEWED BY THE RESEARCHER.

OVERVIEW

A concise summary of research focus, trajectory, and current direction.

Dr. Jinbing Bai studies the biological, psychological, and social mechanisms underlying cancer treatment-related symptoms. His research connects patient-reported outcomes with microbiome and metabolomic data to understand symptom burden, particularly among children and adolescents with cancer. His work examines the microbiome–gut–brain axis and its relationship to pain, fatigue, anxiety, depression, and cognitive difficulties. He earned his doctorate in oncology nursing at UNC-Chapel Hill and completed postdoctoral training at Emory under Dr. Deborah Watkins Bruner.

RESEARCH FOCUS

Ranked by current emphasis.

Primary Areas

  • Cancer Symptom Science and Patient-Reported Outcomes

  • Microbiome–Gut–Brain Axis and Multi-Omics

  • Pediatric and Adolescent Cancer Symptom Research

Secondary Areas

  • Social Determinants of Health and Cancer Care Access

  • Bioinformatics and Reproducible Research Computing

  • Digital Health and AI-Assisted Cancer Education

IMPACT & CURRENT DIRECTION

Summarizes applied impact and ongoing priorities.

Dr. Bai's research seeks to identify mechanisms that can inform targeted interventions to reduce cancer symptom burden and improve quality of life. His projects have received support from NIH and nursing and cancer research organizations. His published work also addresses practical research and care challenges: reproducible microbiome analysis using cloud infrastructure, transportation burdens among patients receiving cancer care, and the quality of AI-generated education for survivors and caregivers.

COLLABORATION INTERESTS

Areas where collaboration may be of interests.

  • Integrating symptom assessments with microbiome and metabolomic data
  • Developing interventions for pediatric cancer symptoms and survivorship
  • Examining social and transportation barriers to cancer care
  • Building reproducible bioinformatics workflows
  • Evaluating accessible, multilingual digital cancer education

METHODS & CONTEXT

Based on published and institutional information.

METHODS

  • Microbiome data analysis and multi-omics integration
  • Longitudinal statistical analysis
  • Instrument development and psychometric testing
  • Patient-reported outcome assessment
  • Cloud-based bioinformatics workflows
  • Expert evaluation of AI-generated health information

APPLICATION CONTEXT

  • Children and adolescents receiving cancer treatment
  • Childhood cancer survivors
  • Adults undergoing chemotherapy or radiotherapy
  • Cancer survivors and family caregivers
  • Patients facing social and transportation barriers

SELECTED WORK

Representative publications. Not a complete list.

  • Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy

    Journal of Translational Medicine, 2024

  • Analysis of travel burden and travel support among patients treated at a comprehensive cancer center in the Southeastern United States

    Supportive Care in Cancer, 2024

  • Evaluation of Large Language Models in Tailoring Educational Content for Cancer Survivors and Their Caregivers: Quality Analysis

    JMIR Cancer, 2025

  • Developing a Reproducible Microbiome Data Analysis Pipeline Using the Amazon Web Services Cloud for a Cancer Research Group: Proof-of-Concept Study

    JMIR Medical Informatics, 2019

ACADEMIC & INSTITUTIONAL ROLES

Positions held by the researcher.

  • Associate Professor with Tenure

    Nell Hodgson Woodruff School of Nursing, Emory University

  • Member, Cancer Prevention and Control Research Program

    Winship Cancer Institute of Emory University

  • Champion, Childhood Cancer & the Environment Program

    National Pediatric Environmental Health Specialty Units initiative

One platform, meaningful change.

From community health to specialized clinical pathways, our platform gives teams everything they need to translate validated care methods into real-world, scalable solutions.